Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03504644
Title Venetoclax and Vincristine Liposomal in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ECOG-ACRIN Cancer Research Group
Indications

acute lymphoblastic leukemia

Therapies

Venetoclax + Vincristine Sulfate

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.